Archive for the ‘BUMC Featured Funding Announcements’ Category

CDMRP DoD Clinical and Rehabilitative Medicine Research Program

Monday, July 21st, 2014

Reconstructive Transplantation Research Funding Opportunity for Fiscal Year 2014

One notable addition in the recent Fiscal year 2014 (FY14) Defense Appropriations Act is $15 million (M) to the Department of Defense for the Reconstructive Transplantation Research Program (RTR) to support the science and execution of complex limb and face transplants. This program is administered by the US Army Medical Research and Materiel Command, the Clinical and Rehabilitative Medicine Research Program (CRMRP), through the Office of Congressionally Directed Medical Research Programs (CDMRP) and the Tissue Injury and Regenerative Medicine Project Management Office. News release was issued on June 20, 2014.
No actual Request for Applications is open yet.  More on this program:  http://cdmrp.army.mil/pubs/press/2014/14rtrppreann.shtml

DoD, VA approve $45 million to fund the Consortium to Alleviate PTSD

Monday, July 21st, 2014

The Consortium to Alleviate PTSD has a Request for Applications (RFA) out for funding affiliated with their award. Detailed descriptions of the CAP funding opportunity, evaluation criteria, and submission requirements can be found in the Request for Applications available electronically for downloading from the CAP website

PhRMA September 1, 2014 Funding Opportunities

Thursday, July 17th, 2014

Over the past 49 years, the PhRMA Foundation has helped thousands of scientists advance their careers and has inspired new generations to enter biopharmaceutical research. The early-career support provided by the PhRMA Foundation has been a catalyst for our scientists to become leaders in their organizations and fields. Our programs help build a larger pool of highly-trained researchers to meet the growing needs of academic institutions, the government and the research-intensive pharmaceutical industry.

The PhRMA Foundation funds scientists at critical points in their research careers to support and reward innovation in disciplines essential to the development of safe and effective medicines. The PhRMA Foundation offers competitive pre and post doctoral fellowships, sabbatical fellowships, and research starter grants to advance science in pharmacology, toxicology, informatics, pharmaceutics, and health outcomes. The Foundation also offers a Comparative Effectiveness Research Center of Excellence Award.

PhRMA Foundation award recipients will continue to play an instrumental role in substantial achievements in medicine for the benefit of public health and ultimately the patient.

BWF Pathogenesis of Infectious Disease Program – BU internal deadline September 9, 2014

Wednesday, July 9th, 2014

Limited Submission Opportunity: Burroughs Wellcome Fund Program for Investigators in the Pathogenesis of Infectious Disease

The Burroughs Wellcome Fund has announced its Investigators in the Pathogenesis of Infectious Disease funding program.  This award provides $500,000 over a period of five years to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters. The awards are intended to give recipients the freedom and flexibility to pursue new avenues of inquiry and higher-risk research projects that hold potential for significantly advancing the biochemical, pharmacological, immunological, and molecular biological understanding of how microbes and the human body interact.

PROGRAM DESCRIPTION:The Investigators in the Pathogenesis of Infectious Disease program provides opportunities for assistant professors to bring multidisciplinary approaches to the study of human infectious diseases. Areas of particular interest include:

  • Cell/Pathogen interactions—studies of host responses at the cell surface, cell signaling in response to infection, microbial persistence in host cells, and other work.
  • Host/Pathogen interactions—studies of how host genetics influences resistance and susceptibility to infection, innate and adaptive immune responses to microbes, pathogen modulation of the immune system, and other work.
  • Novel routes to disease causation—studies of the role of infectious agents in the etiology of chronic, autoimmune, and immunologic diseases, and other work.

ELIGIBILITY: Candidates must be nominated by accredited, degree-granting institutions in the United States or Canada. A U.S. or Canadian institution, including its medical school, graduate schools, and all affiliated hospitals and research institutes, may nominate up to two candidates. However, institutions that nominate a candidate who holds a Doctorate of Veterinary Medicine (D.V.M.) will be allowed three nominations.  Institutions may have a single additional nomination if they nominate a researcher working in pathogenic helminthes, mycology, or reproductive science. Institutions may have one additional nomination if they nominate a member of an underrepresented minority group.

Candidates will generally have an M.D., D.V.M., or Ph.D. degree and must be citizens or permanent residents of the United States or Canada at the time of application. Candidates must have an established record of independent research and hold a tenure-track position as an assistant professor or equivalent at the time of application.

FUNDING INFORMATIONThis award provides $500,000 over a period of five years. No more than $20,000 of the award may be used annually for the grantee’s salary support, including fringe benefits. Indirect costs may not be charged against the award. Grantees must devote at least 75 percent of their time to research-related activities.

AGENCY CONTACT:
Jean Kramarik, Senior Program Associate
Burroughs Wellcome Fund
21 T. W. Alexander Drive
Research Triangle Park, NC 27709
Telephone: 919-991-5122
Email: jkramarik@bwfund.org
Web:   http://www.bwfund.org/grant-programs/infectious-diseases/investigators-pathogenesis-infectious-disease

DEADLINES:
BU Internal Deadline: September 9, 2014
Nomination Deadline: November 3, 2014

INTERNAL REVIEW PROCESS:  Boston University may nominate two candidates for the award.  An internal review committee will select the final nominees.  If you would like to apply, please send the following documents, combined into single pdf file, to Diana Lehman (dlehman@bu.edu) by September 9, 2014:  

  •  A one-page summary of your research
  •  A letter from your research mentor or departmental chair
  •  Your email address and your mentor’s email address
  •  The exact date of your first faculty appointment
  •  Your CV

Limited Submission: Searle Scholars Program

Monday, June 9th, 2014

Searle Scholars Program

The Kinship Foundation/Searle Scholars Program has announced its awards for 2015.   Boston University is invited to submit only one application.  Potential applicants will be reviewed internally to select the final candidate.  If you would like to apply, please send your application to Diana Lehman, Office of Clinical Research  by August 8, 2014.

PROGRAM  DESCRIPTION: 
The Searle Scholars Program makes grants to selected academic institutions to support the independent research of outstanding early-career faculty in the biomedical sciences and chemistry who have recently been appointed as assistant professors on a tenure-track appointment.

ELIGIBILITY:
Applicants for awards, which will be activated on July 1, will be expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences. Candidates should have begun their appointment as an independent investigator at the assistant professor level on or after July 1, 2013 The appointment must be their first tenure-track position (or its nearest equivalent) at an invited institution.

FUNDING INFORMATION:
Grants are $300,000 for a three-year term with $100,000 payable each year of the grant, subject to the receipt of acceptable progress reports. Generally, the program makes 15 new grants each year.

DEADLINES:
Internal Deadline:  August 8, 2014
Foundation Deadline:  September 26, 2014

AGENCY CONTACT:
Douglas M. Fambrough
Scientific Director
Searle Scholars Program
14411 Falls Road
Cockeysville, MD 21030
Telephone: (410) 842-7477
Email: fambro@jhu.edu
Web: http://www.searlescholars.net/go.php?id=5

APPLICATION  PROCESS:
Boston University may submit only one application to the Searle Scholars Program.  Potential applicants will be reviewed internally to select the final candidate.  If you would like to apply, please email the following documents (preferably combined into a single pdf file) to Diana Lehman (dlehman@bu.edu), Office of Clinical Research by August 8, 2014:

  • a one-page summary of your research
  • a letter from your research mentor or departmental chair
  • your email address and your mentor’s email address
  • the exact date of your first faculty appointment
  • and your biosketch or cv

The application process for selected candidates requires online submission.  A complete award program description and application guidelines are available on the Foundation’s web site at http://www.searlescholars.net/go.php?id=1.

Susan Komen – LOI due July 17th

Thursday, June 5th, 2014

For 2014-15, Susan G. Komen will be offering three types of grants

1) Career Catalyst Research Grants ($450,000 over 3 years).

CCR grants provide unique opportunities for scientists who have held faculty positions for no more than six years at the time of full application to achieve research independence. These grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer. Awards may be for basic, translational or clinical research. Pre-Application Submission deadline: July 17, 2014.
Application Instructions

2) Postdoctoral Fellowship Grants ($180,000 for 2-3 years).

PDF grants seek to attract and support promising scientists embarking on careers dedicated to breast cancer research. These grants provide support for research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer. Awards may be for basic, translational, or clinical research. Pre-Application Submission deadline: July 17, 2014
Application Instructions

3) Graduate Training in Disparities Research (Up to $135,000 per year for up to 3 years).

GTDR grants seek to establish or to sustain a training program for a minimum of three graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups. Pre-Application Submission deadline: July 17, 2014.
Application Instructions

LIMITED SUBMISSION! Brain Research Foundation Innovations Award

Wednesday, May 14th, 2014

Brain Research Foundation Scientific Innovations Award

DEADLINES:

  • BU Internal Deadline:  June 9, 2014
  • Foundation Letter of Intent  Deadline:  July 1, 2014

PROGRAM DESCRIPTION

The Brain Research Foundation has invited eligible US institutions to nominate one senior faculty member to submit a Letter of Intent for the Scientific Innovations Award (SIA). The Brain Research Foundation’s Scientific Innovations Award Program provides funding for innovative science in both basic and clinical neuroscience. This funding mechanism is designed to support creative, exploratory, cutting edge research in well-established research laboratories, under the direction of established investigators. The objective of the SIA is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and result in major grant applications and significant publications in high impact journals.

FUNDING INFORMATION

Based on the quality of applications, the Brain Research Foundation anticipates the SIA program will fund a total of $450,000 in grants. Each total award is limited to $150,000 (direct costs) for a two year grant period from the specified dates only (January 2015-December 2016).

ELIGIBILITY

To be eligible, the nominated candidate must be a full-time professor or associate professor at an invited US institution, working in the area of studies of brain function in health and disease. Current major NIH or other peer-reviewed funding is preferred but evidence of such funding in the past three years is essential. Studies should be related to either normal human brain development or specifically identified disease states. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. The grant proposal must detail a new research project that is not funded by other sources. This grant is not to be used as a source of bridge funding.

Investigators at institutions that are affiliated with a medical school or university are eligible to apply only through the institution where they hold a full-time faculty position.  Only one PI may apply per application.
Please note: research associate professors/research professors are not eligible for this award.

APPLICATION PROCESS

The Brain Research Foundation will only accept one Letter of Intent per institution.  Applications must be submitted electronically via the BRF grants website (www.research.thebrf.org) as a single, combined electronic document (PDF) using the BRF LOI and Application forms (provided on the website upon registration).

DEADLINES:

  • BU Internal Deadline:  June 9, 2014
  • Foundation Letter of Intent  Deadline:  July 1, 2014

AGENCY CONTACT

Brain Research Foundation
Web site:  http://thebrf.org/Grants/Scientific+Innovations+Award
Email: info@theBRF.org
Tel:  312-759-5150

INTERNAL REVIEW PROCESS

Boston University is limited to nominating one candidate. If we have more than one interested applicant, an internal review committee will select the candidates for the Institution.  Faculty wishing to be considered for nomination should send the following documents, preferably combined into a single pdf file, to Diana Lehman (dlehman@bu.edu) by June 9, 2013:

  • a one-page summary of your research
  • your biosketch; and
  • your email address

NIH commits up to $2.5 million to research on environmental risk factors for AUTISM – DUE July 26!

Monday, May 12th, 2014

The National Institutes of Health (NIH) has announced two new funding opportunities for research projects aimed at advancing understanding of environmental contributors to autism spectrum disorder. In scientific terms, “environmental” refers to a broad range of non-genetic influences. In the case of autism, research has implicated factors as varied as maternal nutrition and birth complications to exposure to air pollution during pregnancy and early infancy.

The first funding opportunity is an “exploratory” research project with funding of up to $275,000 a year for two years.  See details here: PAR-14-202

The second opportunity is for a full-fledged research project with funding up to $400,000 a year for up to 5 years. More information about this funding opportunity can be found here: PAR-14-203

 

Alpha-1 Foundation – Gordon L. Snider Scholar Award applications due July 25, 2014

Friday, May 9th, 2014

The Alpha-1 Foundation is accepting applications for a new research grant, the Gordon L. Snider Scholar Award.

  • Amount available: up to $225,000 ($75,000/year) over three years.
  • Deadline to apply is July 25, 2014

The award is named after Gordon L. Snider, MD, one of the most influential researchers in Alpha-1. Snider not only made seminal scientific contributions clarifiying Alpha-1-related lung disease, but also laid the groundwork for the Foundation’s research program. In particular, he stressed the importance of encouraging young investigators to pursue a career in Alpha-1 research.

The award’s objective is to provide additional career development support for outstanding young investigators who have continued to conduct research in Alpha-1-related lung or liver disease after completion of their postdoctoral fellowship. It is expected that the award will provide an incentive for a career in Alpha-1 research.

Snider, who died on June 8, 2013 at age 91, founded the pulmonary section of the Boston University School of Medicine and was chief of medical service at the Boston VA Medical Center for 14 years. He served for a decade on the Alpha-1 Foundation’s board of directors. He also served as president of the American Thoracic Society.

 

NHLBI & Lasker Foundation announce 2014-2015 Lasker Clinical Research Scholars in Vascular Medicine

Friday, May 2nd, 2014

The National Heart Lung and Blood Institute (NHLBI) at National Institutes of Health, in partnership with the Lasker Foundation, is pleased to announce the 2014 – 2015 Lasker Clinical Research Scholars Program. The Lasker program supports a small number of exceptional clinical researchers in the early stages of their careers to promote their development as independent investigators. This is an opportunity for up to 12 years of continuous funding for clinical researchers.

LOI due: June 2, 2014
Full application: July 29, 2014

We are seeking Physician-Scientists,with a strong record of achievement in Vascular Medicine, Vascular Genetics and Rare Vascular Diseases. Qualified candidates must have a demonstrated ability to develop an independent translational program that combines basic experimental approaches with clinical research and proven ability to receive early-career award funding. We are looking for candidates that will develop new strategies to translate genetic technologies and advanced disease modeling systems towards Proof of Concept Clinical Studies in patients with vascular diseases at the NIH Clinical Center.

To insure a programmatic fit, applicants must first obtain a Letter of Support by submitting a Biosketch and a summary of research interests. The deadline is June 2, 2014. The full application will include a research proposal and submission of four letters of reference. The deadline for the competed application is July 29, 2014. The positions will start in 2015.

More information and links to the application RFA are available at http://www.nih.gov/science/laskerscholar/index.html
For general questions related to the Lasker scholar program contact Dr. Charles Dearolf, Assistant Director for Intramural Research at NIH, at LaskerScholar@nih.gov.
For questions related to the NHLBI Vascular medicine Lasker scholar recruitment, contact, Dr. Manfred Boehm, Senior Investigator at NHLBI, at boehmm@nhlbi.nih.gov.

The program honors the contributions of Mary and Albert Lasker to the National Institutes of Health and to the overall biomedical community. The Lasker Foundation will provide Scholars with the opportunity to participate in selected activities. The NIH and the Lasker Foundation recognize a unique and compelling need to promote diversity in the clinical research workforce to improve the nation’s capacity to address and eliminate health disparities. The NIH encourages applications from talented researchers from diverse backgrounds underrepresented in biomedical research, including underrepresented racial and ethnic groups, persons with disabilities and women.